Molecular switches based on cis/trans isomerization of bf2-coordinated azo compounds
AssigneeTrustees of Dartmouth College
InventorsIvan Abrahamian, Russel P. Hughes, Yin Yang
Life of this patent
Estimating the term…
Abstract
Provided herein are photochromic organic compounds of Formula I or Formula II, which are useful as molecular switches capable of being triggered via a cis/trans isomerization process. Methods of using the molecular switch compounds to form photopharmaceutical compounds that may be used to provide selective spatiotemporal activation of pharmaceutical agents are also disclosed.
Claims30
A compound of the Formula II:
- or a salt thereof, wherein
- N═N—R2 can be oriented cis or trans to the tricycle;
- R1 is H, CN, CO2H, CO2(C1-6-alkyl), C1-6-alkyl, C6-19-aryl, OH, O(C1-6-alkyl), OC(O)(C1-6-alkyl), NH2, NH(C1-6-alkyl), N(C1-6-alkyl)2, or NHC(O)(C1-6-alkyl);
- R2 is C6-19-aryl or C3-14-heteroaryl;
- and
- R3, R4, R5, R6, R7 and R8 are each, independently, H, C1-6-alkyl, C6-19-aryl, OH, O(C1-6-alkyl), OC(O)(C1-6-alkyl), NH2, NH(C1-6-alkyl), N(C1-6-alkyl)2, NHC(O)(C1-6-alkyl) or a group corresponding to a small molecule pharmaceutical;
- or
- R3 and R4, R4 and R5, R5 and R6 or R7 and R8 can, when taken together, form a fused aryl, fused heteroaryl, fused C3-6-cycloalkyl, or fused heterocycle, wherein the fused aryl, fused heteroaryl, fused cycloalkyl, or fused heterocycle can be optionally substituted one or more times with C1-6-alkyl, C6-19-aryl, OH, O(C1-6-alkyl), OC(O)(C1-6-alkyl), NH2, NH(C1-6-alkyl), N(C1-6-alkyl)2, or NHC(O)(C1-6-alkyl).
A photochromic molecular switch comprising at least one compound of the Formula II:
- or a salt thereof, wherein
- N═N—R2 can be oriented cis or trans to the tricycle;
- R1 is H, CN, CO2H, CO2(C1-6-alkyl), C1-6-alkyl, C6-19-aryl, OH, O(C1-6-alkyl), OC(O)(C1-6-alkyl), NH2, NH(C1-6-alkyl), N(C1-6-alkyl)2, or NHC(O)(C1-6-alkyl);
- R2 is C6-19-aryl or C3-14-heteroaryl;
- and
- R3, R4, R5, R6, R7 and R8 are each, independently, H, C1-6-alkyl, C6-19-aryl, OH, O(C1-6-alkyl), OC(O)(C1-6-alkyl), NH2, NH(C1-6-alkyl), N(C1-6-alkyl)2, or NHC(O)(C1-6-alkyl);
- or
- R3 and R4, R4 and R5, R5 and R6 or R7 and R8 can, when taken together, form a fused aryl, fused heteroaryl, fused C3-6-cycloalkyl, or fused heterocycle, wherein the fused aryl, fused heteroaryl, fused cycloalkyl, or fused heterocycle can be optionally substituted one or more times with C1-6-alkyl, C6-19-aryl, OH, O(C1-6-alkyl), OC(O)(C1-6-alkyl), NH2, NH(C1-6-alkyl), N(C1-6-alkyl)2, or NHC(O)(C1-6-alkyl).
A method of switching a molecular switch, wherein the molecular switch comprises a compound of Formula I or salt thereof wherein the method comprises applying electromagnetic radiation to the molecular switch at a first wavelength effective to cause the trans→cis isomerization of the compound of Formula I or salt thereof or applying electromagnetic radiation to the molecular switch at a second wavelength effective to cause the cis→trans isomerization of the compound of Formula I or salt thereof or a combination thereof.
A method of treating a patient in need of therapy, comprising:
- administering a therapeutically effective amount of the photopharmaceutical compound of claim 27 to a patient in need thereof;
- and
- applying electromagnetic radiation to a tissue comprising the photopharmaceutical compound at a first wavelength effective to cause the trans→cis isomerization or applying electromagnetic radiation to the photopharmaceutical compound at a second wavelength effective to cause the cis→trans isomerization or a combination thereof, wherein one isomer has a higher binding affinity for a target of the tissue than the other isomer.
Dependencies are inferred from the claim text.